Burning Rock Biotech Limited (BNR) Misses Q2 EPS by RMB 1.20

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q2 EPS of (RMB2.50), RMB1.20 worse than the analyst estimate of (RMB1.30). Revenue for the quarter came in at RMB130.8 million versus the consensus estimate of RMB150.5 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c